5 HSCT Articles You Can’t Miss
1. HSCT Seen as Superior to Current Therapies for Severe, Progressive Sclerosis
“Autologous hematopoietic stem cell transplantation (HSCT), evaluated in 18 people with rapidly progressing systemic sclerosis, found the experimental therapy superior to standard treatments for the disease for this patient population.”
2. Spotlight on an Ssc Patient and Stem Cell Therapy: Katrina Brown
“‘My name is Katrina and I served in the British Army 1999-2004 as a Combat Medical Technician. Feeling ill with a variety of symptoms including increasingly severe Raynaud’s, it wasn’t until April 2008 that I was diagnosed with scleroderma. “
3. Hematopoietic Stem Cell Transplant (HSCT): A Patient’s Perspective
4. Human Stem Cell Transplantation Revealed As Promising Treatment For Systemic Sclerosis
From a therapeutic perspective, though a variety of anti-inflammatory drugs are available to treat the symptoms, there is currently no cure for patients with SSc. A recent paper by Dr. N. Krivoruchko suggests the possibility of using human stem cell transplantation (HSCT) to treat the disease.
5. Stem Cell Transplantation Benefits 94% of Diffuse Cutaneous SSc Patients
Autologous haematopoietic stem cell transplantation (AHSCT) has become quite popular for treating patients with systemic sclerosis (SSc). Popularity aside, a limited number of clinical trials had prevented researchers from investigating long-term outcomes of AHSCT in patients with severe diffuse cutaneous SSc.
Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.